Combined immunotherapy for hepatocellular carcinoma: How to maximize immune checkpoint blockade synergic anti-tumor effect
Yujie Huang(Kaohsiung Chang Gung Memorial Hospital), Jiazhi Liao(Tongji University), Dean Tian(Tongji Hospital), Mei Liu(Nanchang University), Lina Feng(Inner Mongolia University), Ruonan Dong(Shanghai Jiao Tong University), Yu Zhang(Tongji Hospital), Mingyu Zhang(Jilin University), Jingmei Liu(Tongji Hospital), Jia‐Lun Guan(Tongji Hospital), Suhong Xia(Center for Digestive and Liver Diseases), Kai Zhao(Qingdao University)
Cited by 13
Related Papers
The clinical characteristics of pneumonia patients coinfected with 2019 novel coronavirus and influenza virus in Wuhan, China
|Journal of Medical Virology|2020|431
Regulatory T-cell and neutrophil extracellular trap interaction contributes to carcinogenesis in non-alcoholic steatohepatitis
|Journal of Hepatology|2021|378
Smartphone-based platforms implementing microfluidic detection with image-based artificial intelligence
|Nature Communications|2023|248
Evaluating the Association of Clinical Characteristics With Neutralizing Antibody Levels in Patients Who Have Recovered From Mild COVID-19 in Shanghai, China
|JAMA Internal Medicine|2020|240
CXCL9: evidence and contradictions for its role in tumor progression
|Cancer Medicine|2016|177